207 related articles for article (PubMed ID: 16704535)
21. Expression of p75NGFR TrkA, and TrkB mRNA in rat C6 glioma and type I astrocyte cultures.
Hutton LA; deVellis J; Perez-Polo JR
J Neurosci Res; 1992 Jul; 32(3):375-83. PubMed ID: 1279189
[TBL] [Abstract][Full Text] [Related]
22. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma.
Ødegaard E; Staff AC; Abeler VM; Kopolovic J; Onsrud M; Lazarovici P; Davidson B
Hum Pathol; 2007 Jan; 38(1):140-6. PubMed ID: 16996570
[TBL] [Abstract][Full Text] [Related]
23. Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression.
Fujimoto M; Kitazawa R; Maeda S; Kitazawa S
Oncogene; 2005 Jul; 24(32):5108-18. PubMed ID: 15870692
[TBL] [Abstract][Full Text] [Related]
24. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
[TBL] [Abstract][Full Text] [Related]
25. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
26. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
[TBL] [Abstract][Full Text] [Related]
27. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer.
Zhu Z; Friess H; diMola FF; Zimmermann A; Graber HU; Korc M; Büchler MW
J Clin Oncol; 1999 Aug; 17(8):2419-28. PubMed ID: 10561305
[TBL] [Abstract][Full Text] [Related]
28. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
29. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
[TBL] [Abstract][Full Text] [Related]
30. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
Stephan H; Zakrzewski JL; Bölöni R; Grasemann C; Lohmann DR; Eggert A
Pediatr Blood Cancer; 2008 Feb; 50(2):218-22. PubMed ID: 17973327
[TBL] [Abstract][Full Text] [Related]
31. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma.
Ben QW; Wang JC; Liu J; Zhu Y; Yuan F; Yao WY; Yuan YZ
Ann Surg Oncol; 2010 Aug; 17(8):2213-21. PubMed ID: 20162456
[TBL] [Abstract][Full Text] [Related]
32. Combined evaluation of NGF and p75NGFR expression is a biomarker for predicting prognosis in human invasive ductal breast carcinoma.
Sakamoto Y; Kitajima Y; Edakuni G; Hamamoto T; Miyazaki K
Oncol Rep; 2001; 8(5):973-80. PubMed ID: 11496301
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
34. Overexpressions of nerve growth factor and its tropomyosin-related kinase A receptor on chordoma cells.
Park JB; Lee CK; Koh JS; Lee JK; Park EY; Riew KD
Spine (Phila Pa 1976); 2007 Aug; 32(18):1969-73. PubMed ID: 17700442
[TBL] [Abstract][Full Text] [Related]
35. Nerve growth factor and its monocyte receptors are affected in kidney disease.
Antonucci MT; Bonofiglio R; Papalia T; Caruso F; Caroleo MC; Mancuso D; Aloe L
Nephron Clin Pract; 2009; 111(1):c21-8. PubMed ID: 19169037
[TBL] [Abstract][Full Text] [Related]
36. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
38. Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma.
Uehara H; Miyamoto M; Kato K; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Hase R; Takahashi R; Mega S; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
Cancer Res; 2004 May; 64(10):3533-7. PubMed ID: 15150108
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of NGF receptors in human thymic epithelial tumors.
Parrens M; Dubus P; Groppi A; Velly JF; Labouyrie E; de Mascarel A; Merlio JP
Pathol Res Pract; 1999; 195(8):549-53. PubMed ID: 10483585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]